搜尋結果
South Korean Contract Research Organization, LSK, spoke in a webinar with ArisGlobal to address the pressures of modernizing pharmacovigilance operations in the current landscape, including how South Korean biopharma firms are navigating evolving regulatory requirements, and how they are seizing the opportunity provided by advancements in ...
China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software.
Safety signal validation and assessment—particularly for serial case assessments—is a time, cost, and labor-intensive process that slows down your operations, delays time to insight, and adds to risk physician burnout. Now, there is a better way. Picking Up Where Traditional Signal Detection Ends.
2017年6月6日 · AstraZeneca selects ArisGlobal LifeSphere® Signal and Risk Management. Next-Generation, Multi-Tenant Cloud Solution Offers Enhanced Capabilities for the Complete Management of Safety Signals for Improved Benefit-Risk Decisions.
Regulatory Factsheet: LifeSphere RIMS. ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere ®, integrates our proprietary cognitive computing engine to automate all core functions of the drug ...
A thirty-year veteran of the life sciences R&D software industry that counts 30 of the top 50 global biopharma companies and six global health authorities – including the US FDA – among its customer base, ArisGlobal’s growth is fueled by a trend toward digital transformation within life sciences companies.
2020年12月7日 · ArisGlobal Announces New Executive Positions to Drive Continued Growth. MIAMI, FL December 7, 2020 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today announced several key executive hires as it continues to accelerate growth across its global markets.
